by ValueVerge
Discussions on the latest quarterly earnings reports from growth and value stocks.
Language
🇺🇲
Publishing Since
10/14/2024
Email Addresses
1 available
Phone Numbers
0 available
April 26, 2025
<p>$ABBV is releasing its Q1 2025 earnings results today. They reported an EPS of $2.46, surpassing expectations by $0.06, and revenue of $13.34B, which is 8.39% higher year-over-year. Key highlights include robust growth from their ex-Humira platform, particularly in immunology, and strong demand for Skyrizi and Rinvoq. However, Humira faced a significant sales decline, down nearly 50%. Future risks might include sector tariffs impacting guidance, but overall, the outlook remains positive. 📊💰 Check details in valueverge.com/ABBV.</p>
April 25, 2025
<p>$CMCSA has released its Q1 2025 earnings report, showing an EPS of $1.09, beating estimates by $0.10, while revenue came in at $29.89B, a slight decline of 0.57% year-over-year. Key stats reveal solid profitability with a 5% adjusted EPS growth and $5.4B in free cash flow.<br></p>
April 25, 2025
<p>$PEP has released its Q1 2025 earnings, with an EPS of $1.48, missing estimates by $0.01, and revenue of $17.92B, a slight decline of 1.81% Y/Y yet beating expectations by $190.27M. Key highlights include profitability risks tied to ongoing tariffs and consumer pressures, while growth from the international segment remains a strong point. Future opportunities involve strategic investments in pricing and enhanced operational efficiency. 📉👀🌍 Full details at valueverge.com/PEP.</p>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
